CXCL2 and pulmonary fibrosis: Taken together, aesculetin may antagonize pulmonary fibrosis and alveolar epithelial barrier disruption triggered by infiltration of monocyte-derived macrophages—which is typical of PHMG toxicity—involving interaction of MIP-2 and CXCR2.